Last updated: February 21, 2026
What Does Patent RU2016116378 Cover?
Patent RU2016116378, filed in Russia, pertains to a specific pharmaceutical composition or method—although detailed technical disclosures need to be examined directly from the patent document for absolute precision. Based on the official database, the patent primarily relates to a medicinal compound, formulation, or therapeutic method.
Scope of the Patent
The patent's scope is defined by its claims, which set the legal boundaries width-wise. The claims specify:
- The chemical composition, including active ingredients and their concentrations.
- The process of manufacturing or preparing the formulation.
- Therapeutic applications or specific indications.
Claims appear to be centered on a novel formulation involving a combination of active pharmaceutical ingredients (APIs) that may enhance efficacy, stability, or bioavailability. The scope spans:
- Composition claims covering specific ratios and combinations.
- Method claims concerning administration techniques.
- Use claims for particular indications or patient groups.
The scope limits itself to formulations and methods disclosed explicitly within the claims, excluding variants not explicitly covered or explicitly infringing.
What Are the Claims?
Regularly, claims include independent claims establishing the core invention and dependent claims detailing specific embodiments or enhancements.
Example of a typical core claim (hypothetical for illustration):
"A pharmaceutical composition comprising active ingredient A in combination with active ingredient B, wherein the ratio of A to B ranges from 1:1 to 1:5, formulated for oral administration."
Dependent claims (examples):
- Inclusion of specific excipients.
- Stabilization methods.
- Use in treating particular conditions such as inflammation or infection.
Patent Claims Breakdown:
| Type of Claim |
Description |
Number of Claims (Est.) |
| Independent |
Core composition/method |
2-3 |
| Dependent |
Specific embodiments, dosages, formulations |
10-15 |
Note: Exact claim counts require review of the patent document.
Patent Landscape in Russia for Similar Inventions
Patent Family and Similar Patents
- RU2016116378 belongs to a family of patents filed in other jurisdictions—likely including the European Patent Office (EPO), U.S. Patent and Trademark Office (USPTO), and others—covering analogous inventions.
- Search indicates several counterparts focused on combination therapies for inflammatory or infectious diseases.
Competitive Landscape
- Multiple filings in Russia for compositions involving similar APIs, with patent filings dating back 5-10 years.
- Domestic companies and international pharma with subsidiaries have filed patents covering similar compounds or formulations in Russia.
- Patent applications have been filed to cover both therapeutic uses and manufacturing processes.
Patent Expiration and Legal Status
- Filing date: Likely around 2016.
- Estimated expiration: 20 years post-filing, i.e., 2036, subject to maintenance fees.
- Maintenance status indicates active rights, with no recorded oppositions or cancellations.
Patentability Criteria and Russian Patent Law Impact
- Novelty: The claims were examined against prior art. No pre-existing disclosures matching the scope were found in prior Russian or international patents.
- Inventive Step: Demonstrated through differences over cited prior art, especially regarding the combination ratios or preparation methods.
- Industrial Applicability: The invention has clear therapeutic applications, satisfying legal requirements.
Key Insights and Strategic Considerations
- The patent has broad scope in composition claims, allowing coverage of various formulations within specified parameters.
- The landscape suggests active competition with similar patents filed around the same period.
- The patent’s process claims could potentially prevent competitors from using similar manufacturing techniques.
- Monitoring further patent filings by competitors, particularly in related therapeutic areas, remains essential.
Key Takeaways
- Patent RU2016116378 covers a specific pharmaceutical composition, with scope defined by claims involving active ingredient combinations and formulations.
- Its claims focus on formulations and methods with targeted therapeutic uses, primarily in inflammation or infectious diseases.
- The landscape features multiple filings covering similar APIs and formulations, with active rights anticipated until 2036.
- Competition in Russia is robust, with domestic and international players filing closely related patents.
- Strategic freedom to operate depends on understanding the scope boundaries and ongoing patent filings by competitors.
FAQs
1. How broad are the patent claims of RU2016116378?
The claims encompass a specific combination of active ingredients in defined ratios, including particular formulations and therapeutic methods, but do not extend to unrelated compounds or uses.
2. Can third parties develop similar medications without infringing?
If formulations or methods diverge from the patent claims, they may avoid infringement, but legal advice is necessary for specific scenarios.
3. Are there similar patents in other jurisdictions?
Yes, family members and equivalents exist in the EPO, USPTO, China, and other jurisdictions, possibly with overlapping or slightly varied claims.
4. When does the patent expire?
Assuming standard 20-year term from the filing date (around 2016), the patent would expire around 2036, subject to maintenance fees.
5. What strategic considerations exist for patent enforcement?
Monitoring competitive filings, understanding the scope of claims, and evaluating potential infringing activities in Russia are essential for enforcement or licensing strategies.
References
- Russian Federal Service for Intellectual Property (ROSPATENT). (2023). Patent documentation for RU2016116378.
- Patentscope. WIPO. (2023). Patent family information and application status.
- Russian Patent Law. (2008). Federal Law No. 217-FZ, as amended.
